उत्पाद वर्णन
Description
- Each Uncoated Modified Release Tablet Containes: Gliclazide IP 60 mg
Indication
- Gliclazide is one of a group of medicines called sulfonylureas that are used to lower the blood sugar level.
- Gliclazide tablets are used to treat maturity onset diabetes in patients that is not controlled by diet alone.
- They are not for use in children or in patients with diabetes requiring insulin
Advanced Blood Sugar ManagementThese modified release Gliclazide tablets provide steady glucose regulation over a 24-hour period, helping patients maintain optimal blood sugar levels. This sustained effect reduces fluctuations and supports effective daily diabetes management with reduced dosing frequency.
Quality-Assured Ingredients and ManufacturingEach tablet contains 60 mg of Gliclazide combined with pharmaceutical-grade excipients, ensuring consistent absorption and safety. Manufactured and distributed by trusted entities across India, strict quality controls guarantee reliability and patient trust.
Convenient Storage and LongevityWith a recommended storage temperature below 30C, these tablets maintain stability and effectiveness for up to 36 months, making them suitable for long-term use and easy inventory management for distributors and suppliers.
FAQ's of Gliclazide IP 60 mg Modified Release Tablet:
Q: How should Gliclazide IP 60 mg Modified Release Tablets be stored?
A: Store the tablets below 30C in a dry place, away from direct sunlight, to maintain their effectiveness throughout their 36-month shelf life.
Q: What is the benefit of the modified release formulation of Gliclazide 60 mg?
A: The modified release feature ensures a sustained release of the active ingredient over 24 hours, minimizing blood sugar fluctuations and reducing the need for multiple daily doses.
Q: When should this medication be taken for optimal results?
A: It is generally recommended to take the tablet once daily, at the same time each day, ideally with breakfast or as directed by your healthcare provider.
Q: Where can these tablets be sourced in India?
A: Gliclazide IP 60 mg Modified Release Tablets are available through a network of dealers, distributors, exporters, importers, manufacturers, retailers, suppliers, and wholesalers across India.
Q: What is the process for supplying these tablets to healthcare facilities?
A: Manufacturers produce the tablets under stringent protocols, and they are then distributed through authorized supply chains to pharmacies, hospitals, and other healthcare outlets.
Q: How is the tablet appearance designed to assist usage?
A: The tablet is white, oblong, and scored, making it easy to identify and, if necessary, to split for accurate dosing as recommended by a healthcare professional.